Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy

Elvin Kedhi, Azeem Latib, Alexandre Abizaid, David Kandzari, Ajay J. Kirtane, Roxana Mehran, Matthew J. Price, Daniel Simon, Stephen Worthley, Azfar Zaman, Sandeep Brar, Minglei Liu, Gregg W. Stone, Stephan Windecker

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences